Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geke A H van den Elsen

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the American Geriatrics Society|February 14, 2014
Medicinal use of cannabis and cannabinoids in older adults: where is the evidence?Amir I A Ahmed, Geke A H van den Elsen, Marjolein A van der Marck, et al.
Journal of the American Geriatrics Society|May 16, 2014
Cannabinoids for pain in dementia: the good, the bad, and the uglyAmir I A Ahmed, Geke A H van den Elsen, Marjolein A van der Marck, et al.
Rheumatology (Oxford, England)|March 31, 2021
Effectiveness and tolerability of oral vs subcutaneous methotrexate in patients with rheumatoid arthritisJanne Heuvelmans, Nathan den Broeder, Geke A H van den Elsen, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 13, 2015
Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled TrialGeke A H van den Elsen, Amir I A Ahmed, Robbert-Jan Verkes, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[Topical NSAIDs: ineffective or undervalued?]Noortje van Herwaarden, Geke A H van den Elsen, Ingrid C A de Jong, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 24, 2019
[Medicinal cannabis]Geke A H van den Elsen, Florentien E M In 't Hout, Marjan de Vries, et al.
Psychopharmacology|March 11, 2015
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementiaAmir I A Ahmed, Geke A H van den Elsen, Angela Colbers, et al.
Neurology|May 15, 2015
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trialGeke A H van den Elsen, Amir I A Ahmed, Robbert-Jan Verkes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 19, 2014
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trialAmir I A Ahmed, Geke A H van den Elsen, Angela Colbers, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the American Geriatrics Society|February 14, 2014
Medicinal use of cannabis and cannabinoids in older adults: where is the evidence?Amir I A Ahmed, Geke A H van den Elsen, Marjolein A van der Marck, et al.
Journal of the American Geriatrics Society|May 16, 2014
Cannabinoids for pain in dementia: the good, the bad, and the uglyAmir I A Ahmed, Geke A H van den Elsen, Marjolein A van der Marck, et al.
Rheumatology (Oxford, England)|March 31, 2021
Effectiveness and tolerability of oral vs subcutaneous methotrexate in patients with rheumatoid arthritisJanne Heuvelmans, Nathan den Broeder, Geke A H van den Elsen, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 13, 2015
Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled TrialGeke A H van den Elsen, Amir I A Ahmed, Robbert-Jan Verkes, et al.
Nederlands Tijdschrift Voor Geneeskunde|August 4, 2021
[Topical NSAIDs: ineffective or undervalued?]Noortje van Herwaarden, Geke A H van den Elsen, Ingrid C A de Jong, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 24, 2019
[Medicinal cannabis]Geke A H van den Elsen, Florentien E M In 't Hout, Marjan de Vries, et al.
Psychopharmacology|March 11, 2015
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementiaAmir I A Ahmed, Geke A H van den Elsen, Angela Colbers, et al.
Neurology|May 15, 2015
Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trialGeke A H van den Elsen, Amir I A Ahmed, Robbert-Jan Verkes, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 19, 2014
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: a randomized controlled trialAmir I A Ahmed, Geke A H van den Elsen, Angela Colbers, et al.
Pageof 1